Why the study?
Does catheter-based renal denervation reduce blood pressure in patients with resistant hypertension?
Does catheter-based renal denervation reduce blood pressure in patients with resistant hypertension?
Catheter-based renal denervation is an emerging interventional strategy for resistant hypertension with promising efficacy and safety, though long-term durability and expanded indications remain to be established.
Answers are grounded in this paper and cite their sources.
Promising results for renal denervation in resistant hypertension should not yet change practice; leaves open long-term durability and optimal indications.
Adequate blood pressure control represents an important goal for all physicians due to the complications of hypertension which reduce patients' quality of life. A new interventional strategy to reduce blood pressure has been developed for patients with resistant hypertension. Catheter-based renal denervation has demonstrated excellent results in recent investigations associated with few side effects. With the growing diffusion of this technique worldwide, some medical societies have published consensus statements to guide physicians how to best apply this procedure. Questions remain to be answered such as the long-term durability of renal denervation, the efficacy in patients with other sympathetically mediated diseases, and whether renal denervation would benefit patients with stage 1 hypertension.
No takes yet. Share an insight, caveat, or question.
Torres et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: